Signaling by eNOS through a superoxide-dependent p42/44 mitogen-activated protein kinase pathway

Expression ofendothelial nitric oxide synthase (eNOS) in transfected U-937 cellsupregulates phorbol 12-myristate 13-acetate (PMA)-induced tumornecrosis factor- (TNF-) production through a superoxide(O)-dependent mechanism. Because mitogen-activatedprotein kinases (MAPK) have been shown to participate in both reactiveoxygen species signaling and TNF- regulation, their possible role ineNOS-derived O signal transduction was examined. Aredox-cycling agent, phenazine methosulfate, was found to bothupregulate TNF- (5.8 ± 1.0 fold; P = 0.01) andincrease the phosphorylation state of p42/44 MAPK (3.1 ± 0.2 fold; P = 0.01) in PMA-differentiated U-937 cells. AlthoughS-nitroso-N-acetylpenicillamine, a nitric oxide(NO) donor, also increased TNF- production, NO exposure led tophosphorylation of p38 MAPK, not p42/44 MAPK. Upregulation of TNF-production by eNOS transfection was associated with increases inactivated p42/44 MAPK (P = 0.001), whereas levels ofphosphorylated p38 MAPK were unaffected. Furthermore, cotransfectionwith Cu/Zn superoxide dismutase, which blocks TNF- upregulation byeNOS, also abolished the effects on p42/44 MAPK. Expression ofGln³⁶¹eNOS, a mutant that produces O but not NO, still resulted in p42/44 MAPK phosphorylation. In contrast, twoNADPH binding site deletion mutants of eNOS that lack oxidase activityhad no effect on p42/44 MAPK. Finally, PD-98059, a p42/44 MAPK pathwayinhibitor, blocked TNF- upregulation by eNOS (P = 0.02).Thus O produced by eNOS increases TNF- productionvia a mechanism that involves p42/44 MAPK activation.